Mazdutide for Reducing Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-10-25Est. Completion: 2028-12-30
Enrollment target: 700 participants
Locations
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China., Beijing, China